Introduction
C-mannosylation is a rare type of protein glycosylation in which a-mannose is attached to the indole C2 carbon of a tryptophan residue through a C-C bond in the endoplasmic reticulum (ER) lumen [1] [2] [3] . Cmannosylation occurs at the first tryptophan residue in the consensus amino acid sequence Trp-Xaa-Xaa-Trp/ Cys [4, 5] . C-mannosylation is co-or post-translationally modified by ER-localized enzyme and C-mannosyltransferase uses dolichol-phosphate-mannose as mannose donor, which is synthesized by dolichol-present in human; thus, the human homologs of dpy-19 are likely to be C-mannosyltransferases [12] . Recently, we first reported human DPY19L3 to be a C-mannosyltransferase of R-spondin1 (Rspo1), which harbors the C-mannosylation consensus sequenceTrp 156 -Gly-Pro-Cys-in its TSR [13] . Moreover, Shcherbakova et al. demonstrated that murine DPY19L1 and DPY19L3 are C-mannosyltransferases of the netrin receptor UNC5A [14] .
The structure and topology of membrane proteins have been studied extensively to better understand their functions; however, membrane proteins contain hydrophobic regions, rendering them more difficult to handle compared with soluble proteins. As a consequence, less than 1% of all deposited structures in the Protein Data Bank are those of membrane proteins [15] . Partly due to the lack of 3-dimensional data on membrane proteins, many topology programs have been developed and shown to be superior in predicting the structures of membrane proteins [16] .
Although DPY19L3 is predicted to be a multipass transmembrane (TM) protein that localizes to the ER [17] , the number and orientation of TM domains in DPY19L3 are unknown. To increase our understanding of the structure of DPY19L3 and the mechanism by which catalyzes C-mannosylation, we sought to determine the ER membrane topology of DPY19L3 by combining in silico analysis and experimental methods that uses the redox-sensitive luciferase assay, a rapid and recently reported topological protocol [18] , and the introduction of N-glycosylation sites. In addition, we identified the region of DPY19L3 that is essential for its C-mannosyltransferase activity. These novel topological findings provide important insights into our understanding of the mechanism of C-mannosylation.
Results

In silico analysis of human DPY19L3
To determine the topology of DPY19L3 in the ER membrane, we first performed an in silico analysis of the TM domains in DPY19L3 (UniProt reference Q6ZPD9-1) using several prediction programs: MemBrain [19] , TOPCONS [20] , PolyPhobius [21] , SCAMPI [22] , OCTOPUS [23] , MEMSTAT-SVM [24] , UniProt [25] , Phobius [26] , TMHMM [27] , and SOSUI [28] (Fig. 1 ). Because these programs predicted DPY19L3 to have 11-14 TM regions and because these predictions varied between programs, especially at the N-terminal region (~330 a.a.), we chose to determine the topology of DPY19L3 experimentally.
Analysis of ER membrane topology of DPY19L3 by redox-sensitive luciferase assay
The topology of DPY19L3 was determined by redoxsensitive luciferase assay using Gaussia luciferase (Gluc) [18, 29] . Gluc is a redox reporter that requires an oxidative environment to form disulfide bonds that are essential for its activity [30, 31] . Therefore, the bioluminescent signal of Gluc that has been modified for retention in the ER lumen (oxidizing state) is higher than that of molecules that are confined to the cytoplasm (reducing state).
To analyze Gluc activity with regard to identify the topology of DPY19L3, we constructed plasmids that expressed DPY19L3-Gluc fusion protein, in which Gluc was fused to the N-or C-terminus of full-length DPY19L3 (716-amino-acid protein) or the C-terminus of truncated DPY19L3 at E80, K151, G183, V205, T208, P237, Q262, K285, N307, N339, A400, T456, L486, or Y515 ( Fig. 2A ). 293T cells were transiently transfected with these constructs, and Gluc-catalyzed bioluminescence in cell lysates was measured. Cotransfection with firefly luciferase (Luc)-encoding vector was performed to measure the transfection efficiency. The bioluminescence of 7 Gluc-fused constructs-at E80, K151, Q262, N307, A400, L486, and the C-terminus-was higher versus the other proteins ( Fig. 2B-D) . These results suggested that E80, K151, Q262, N307, A400, L486, and the C-terminus lie in the ER lumen, whereas the N-terminus, G183, V205, T208, P237, K285, N339, T456, and Y515 reside in the cytoplasm.
Determination of N-glycosylation sites in DPY19L3
Human DPY19L3 has four predicted N-glycosylation consensus sites-Asn-Xaa-Ser/Thr (Xaa represents any amino acid except Pro)-at Asn (Fig. 3A) , supporting the accuracy of the results of redox-sensitive luciferase assay. To determine whether DPY19L3 was N-glycosylated only at Asn 118 and Asn 704 , we treated DPY19L3-expressing 293T cells with tunicamycin, an N-glycosylation inhibitor [32, 33] . Treatment of DPY19L3 (wild-type: wt)-expressing cells with tunicamycin decreased the size of DPY19L3 (Fig. 3B) . Furthermore, treatment with peptide-N-glycanase (PNGase) F, a specific glycosidase of N-glycosylation, on DPY19L3 (wt)-expressing cell lysate also decreased the size of DPY19L3, but no such changes were observed in DPY19L3 (2NQ)-expressing cells (Fig. 3B) , demonstrating that DPY19L3 is N-glycosylated only at Asn 118 and Asn
704
.
Determination of ER membrane topology of DPY19L3
In the redox-sensitive luciferase assay, both E80 and K151 lie in the ER lumen (Fig. 2B) , suggesting TM2 region termed in Figs 1 and 2A is re-entrant loop (RL); however, only 3 prediction programs among 10 programs used in this study predicted this region as TM (Fig. 1) . To validate whether this region is RL or not, we introduce NV residues between L 140 and S 141 in this region (141NV-in) (Fig. 3C) . Among 10 programs used in this study, only MemBrain can predict RL and MemBrain predicted this region as RL (Figs 1 and 3C ).
Upon the introduction of N-glycosylation consensus sequence, we confirmed that the topological prediction by MemBrain was not changed between wt and 141NV-in mutation (Fig. 3C) . By the introduction of N-glycosylation site, 2NQ + 141NV-in mutation was partially increased the size of DPY19L3 compared with 2NQ mutation, and this size increment was due to the N-glycosylation confirmed by PNGaseF treatment (Fig. 3D) . We are aware of partial N-glycosylation of 2NQ + 141NV-in mutant; however, we mention that the introduction of artificial N-glycosylation site(s) generally produces partial N-glycosylation if the region localizes to ER lumen [34] . These results indicated that this region is probably not RL but ER luminal region.
The region including V205 and T208 (between TM4 and TM5 termed in Figs 1 and 2A) was presumed as cytoplasmic region by redox-sensitive luciferase assay (Fig. 2C) ; however, the results of redox-sensitive luciferase assay of G183, V205, T208, and P237 suggested that this region flanked by 2 RLs (Fig. 2B,C) . Moreover, R204 and E213 of DPY19L3 were suggested the possible important residues of C-mannosyltransferase activity [12] . Thus, the concept that the region between TM4 and TM5 is ER luminal region but not cytoplasmic region is more reasonable. To further validate the Fig. 1 . Prediction of TM domains in human DPY19L3. In silico analysis of human DPY19L3 amino acid sequence was performed using 10 prediction programs. The regions highlighted in blue were predicted common among the various prediction programs. Underlined regions were predicted as RL by MemBrain.
topology of DPY19L3, we constructed E206N mutant of DPY19L3, resulting in the N-glycosylation consensus sequence ( 206 NFT 208 ) (Fig. 3E) ; however, E206N mutation of DPY19L3 did not induce N-glycosylation (Fig. 3F) , confirming the region is certainly cytoplasmic region. Thus, our in silico analysis and experimental methods using redox-sensitive luciferase assay, analysis of N-glycosylation sites and the introduction of N-glycosylation sites demonstrate that human DPY19L3 has 11 TM domains and two RLs with five luminal and seven cytoplasmic loops (Fig. 3G) .
Effects of N-glycosylation of DPY19L3 at Asn 118 and Asn 704 on C-mannosyltransferase activity
We have reported that human DPY19L3 is the C-mannosyltransferase for Rspo1 at the Trp 156 residue [13] . To determine the effects of N-glycosylation of DPY19L3 on its C-mannosyltransferase activity, we performed gain-of-function experiments using S2 Drosophila melanogaster embryonic cells which have no Cmannosyltransferase activity [12, 13, 35, 36] . To measure C-mannosyltransferase activity, we transiently transfected S2 cells with DPY19L3 (wt, N118Q, or N704Q) and Rspo1, and purified recombinant Rspo1 from each culture media. The mRNA expressions of each DPY19L3 in S2 cells were confirmed by RT-PCR (data not shown). Purified Rspo1 protein bands from SDS/PAGE were digested with trypsin and Asp-N, and the resulting peptides were analyzed by targeted MS/MS. According to the inclusion list of doubly protonated parent ions of un-, mono-, and dimannosylated 152 EWSPWGPCSK 161 peptides, MS/MS spectra were obtained by LC-MS, and selected ion chromatograms of y5 ions of these parent ions were generated (Fig. 4A) . Although Rspo1 has 2 C-mannosylation sites at Trp 153 and Trp
156
, DPY19L3 modified only the latter in S2 cells (Fig. 4A,B) , and Trp 153 -modified mono-or di-mannosylated peptide was not detected as our previous report [13] . Under the same conditions, only Trp 156 of Rspo1 was monomannosylated by N-glycosylation-deficient DPY19L3 (N118Q or N704Q) (Fig. 4A,B) . Furthermore, the ratios between un-and Trp 156 -mono-mannosylated peptides from wt, N118Q, or N704Q mutant DPY19L3-expressing S2 cells were similar (Fig. 4C) , suggesting that N-glycosylation of DPY19L3 is not required for its Cmannosyltransferase activity. Moreover, N118Q and N704Q mutant DPY19L3 were localized in ER similar to wt DPY19L3 (Fig. 4D ) as previously reported [12] . Among human DPY19 family members, the N-glycosylation consensus sequences in DPY19L3 were conserved only in DPY19L4 (Fig. 4E) , supporting our result that N-glycosylation of DPY19L3 is irrelevant to its activity.
Evaluation of C-mannosyltransferase activity of DPY19L3 splice variant isoform2 Fig. 5A ). Based on our topological model (Fig. 3G) , isoform2 lacks the C-terminal luminal region of DPY19L3; however, topological prediction of isoform2 by MemBrain is almost similar to wt DPY19L3, but the last TM region of wt DPY19L3 is changed to RL (Fig. 5A) , resulting in the C-terminus of isoform2 is predicted to localize cytoplasm. By redox-sensitive luciferase assay, the C-terminus of isoform2 has high Gluc activity, as does this segment of DPY19L3 (Fig. 5B) , demonstrating the C-terminus of isoform2 is localized to ER lumen. Furthermore, isoform2 was localized in ER similar to wt DPY19L3 (Fig. 5C) .
Next, we measured the C-mannosyltransferase activity of isoform2 in gain-of-function experiments using S2 cells as described above. The mRNA expression of isoform2 in S2 cells was confirmed by RT-PCR (data not shown). Although un-mannosylated peptide was detected in the proteins that were derived from both DPY19L3 and isoform2-expressing S2 cells by LC-MS/MS, Trp 156 -mono-mannosylated peptide was only detected from DPY19L3-expressing S2 cells (Fig. 5D) . These results suggest that isoform2 has no C-mannosyltransferase activity and that DPY19L3 contains the region of the C-terminus that is essential for C-mannosylation.
Discussion
We have generated the topological structure of DPY19L3 by in silico analysis and experimental methods (Figs 1-3) . We determined that the N-and C-termini of DPY19L3 lie in the cytoplasm and ER lumen, respectively, and that the topological model comprises 11 TM domains and 2 RLs (Fig. 3G) . The RL is inserted halfway through the membrane, traversing back to the side at which it entered [38] . Several proteins bear RLs, such as squalene monooxygenase, hedgehog acyltransferase, and ghrelin O-acyltransferase [39] [40] [41] . We propose that DPY19L3 contains two RLs, one of which is predicted by MemBrain (termed RL3 in Fig. 3G ) and the other is not (termed RL4 in Fig. 3G) [38] ; however, the hydrophobicities of RL3 and RL4 are not lowest among these 13 regions. Thus, it is unlikely that RL3 and RL4 are not inserted into ER membrane and that the region between TM2 and TM5 is long cytoplasmic loop. On the other hand, considering from the hydrophobicities of RL3 and RL4, it is possible that RL3 and RL4 are TM regions but not RLs and the loop flanked by the regions is luminal loop still exists; however, at least under our experimental conditions, the results of redox-sensitive luciferase assay and an introduction of N-glycosylation site strongly supported our proposed topological model.
We also determined the N-glycosylation sites in DPY19L3 and the effects of N-glycosylation on its enzymatic activity (Figs 3 and 4 (Fig. 3A,B) . These results underscore the accuracy of our topological model of DPY19L3. Conversely, Nglycosylation of many proteins is generally required for such functions as secretion, stability, and enzymatic activity [33, [43] [44] [45] [46] [47] . We hypothesized that the Nglycosylation of DPY19L3 at Asn 118 and/or Asn 704 is necessary for its C-mannosyltransferase activity; however, we conclude that it is dispensable for its enzymatic activity, based on gain-of-function experiments in S2 cells (Fig. 4) . Furthermore, by MS/MS analysis, N-glycosylation at Asn 118 and Asn 704 did not alter the sequence specificity of C-mannosylation by DPY19L3 -all mono-mannosylated peptides were C-mannosylated at Trp 156 but not Trp 153 (Fig. 4A,B) . Also, DPY19L3 (N118Q) and DPY19L3 (N704Q) mutants localized to the ER, like wt DPY19L3, as expected (Fig. 4D) . By ClustalW analysis of human DPY19 family proteins, these N-glycosylation sites were not conserved between DPY19 members (Fig. 4E) . In contrast, in other species, including mouse, rat, bovine, and zebrafish, N-glycosylation consensus sequences in DPY19L3, corresponding to human Asn 118 and Asn 704 , were conserved, suggesting the functional implications of N-glycosylation. Further studies are required to determine the significance of N-glycosylation of DPY19L3.
A previous study presumed important amino acids in C. elegans dpy-19 for C-mannosyltransferase [12] . These amino acids are partly conserved in DPY19L3 and correspond to R204 and E213 of DPY19L3; however, considering that C-mannosylation occurs in the ER lumen, it is unlikely that these amino acids, which lies in the cytoplasm, is an important region for Cmannosyltransferase. We evaluated the C-mannosyltransferase activity of isoform2, which lacks the Cterminal luminal region of DPY19L3, and demonstrated that it has no detectable C-mannosyltransferase activity (Fig. 5D) . Thus, the C-terminal luminal region of DPY19L3 must be essential for its enzymatic activity. This region has one N-glycosylation site at Asn 704 , but N-glycosylation is not necessary for catalysis. Consequently, the impairment in C-mannosyltransferase activity by isoform2 is not due to the lack of N-glycosylation at Asn 704 . Furthermore, isoform2 localizes at ER as well as DPY19L3 (Fig. 5C ), suggesting that the absence of C-mannosyltransferase activity by isoform2 is not attributed to alterations in intracellular trafficking. Additional analyses are needed to determine the active site.
In summary, this study is the first report on the topological structure of human DPY19L3. We have determined that DPY19L3 consists of 11 TM domains and 2 RLs with the N-and C-termini facing the cytoplasm and ER lumen, respectively (Fig. 3G) .
Moreover, the C-terminal region of DPY19L3 is essential for its C-mannosyltransferase activity. The novel findings serve as important references for examining the mechanism of C-mannosylation.
Materials and methods
Cell culture
The 293T human embryonic kidney, HT1080 human fibrosarcoma, and S2 Drosophila melanogaster embryonic cell lines were cultured as described [13] .
Plasmid construction
For the redox-sensitive luciferase assay, the human DPY19L3 and Gluc genes were cloned from pIZ-DPY19L3-myc [13] and pGLuc-Basic (New England Biolabs, Inc., Ipswich, MA, USA), respectively. To construct Gluc-fused DPY19L3 expression vectors, the Gluc gene was fused to the N-terminus of full-length wild-type (wt) DPY19L3, the C-terminus of DPY19L3 (wt or isoform2), and the C-terminus of truncated DPY19L3 at the following amino acids, E80, K151, G183, V205, T208, P237, Q262, K285, N307, N339, A400, T456, L486, and Y515. The Gluc fusion constructs were amplified by PCR and inserted into the XhoI/NotI restriction sites in pCI-neo (Promega Corporation, Madison, WI, USA). For pCI-neo-Gluc-DPY19L3 (N-terminus), Gluc and DPY19L3 were amplified using the primers shown in Table S1 and fused by overlap extension technique. For pCI-neo-DPY19L3-Gluc (C-terminus), DPY19L3 and Gluc were amplified using the primers shown in Table S1 and fused by overlap extension technique. For pCI-neo-DPY19L3 (E80, V205, P237, N339, A400, T456, L486, and Y515)-Gluc, truncated DPY19L3 and Gluc were amplified using the primers shown in Table S1 and fused by overlap extension technique. For pCI-neo-DPY19L3 (K151, G183, T208, Q262, K285, N307, and isoform2)-Gluc, inverse PCR was performed using the primers shown in Table S1 .
To analyze the N-glycosylation sites in DPY19L3, we constructed pCI-neo-DPY19L3 [N118Q, N319Q, N439Q, N704Q, and N118Q/N704Q (2NQ)]-Gluc by site-directed mutagenesis technique as previously described method [13] using the primers shown in Table S1 .
For the topological analysis by the introduction of Nglycosylation sites, we constructed pCI-neo-DPY19L3 (2NQ + 141NV-in and 2NQ + E206N), inverse PCR was performed using the primers shown in Table S1 and pCIneo-DPY19L3 (2NQ)-Gluc as template.
To analyze the intracellular localization of DPY19L3, DPY19L3 genes (wt, N118Q, N704Q, and isoform2) were amplified by PCR using the primers shown in Table S1 and pCI-neo-DPY19L3 (wt, N118Q, N704Q, and isoform2) as template, respectively, and inserted into XhoI/BamHI restriction sites in pAcGFP1-N1 (Clontech Laboratories, Mountain View, CA, USA). We constructed pIZ-DPY19L3 (N118Q and N704Q)-myc for expression in S2 cells by site-directed mutagenesis (N118Q and N704Q) using the primers shown in Table S1 and pIZ-DPY19L3-myc [13] as template. pIZ-DPY19L3 (isoform2)-myc was generated by inverse PCR using the primers shown in Table S1 and pIZ-DPY19L3-myc as template. pMT-PURO-Rspo1-myc-his 6 was constructed earlier [13] .
Redox-sensitive luciferase assay
We performed the redox-sensitive luciferase assay using a slightly modified version of an existing method [29] . 293T cells were seeded into 24-well plates. After being cultured for 24 h, the cells were transiently transfected with 100 ng of Gluc-fused plasmids and 50 ng of pZeo-luc using polyethyleneimine (PEI) Max (Polysciences, Inc., Warrington, PA, USA). After 24 h, the cells were lysed, and Gluc and Luc activities were measured using the Renilla Luciferase Assay System (Promega Corporation) and the Luciferase Assay System (Promega Corporation), respectively, on an Infinite 200 Pro (Tecan Group Ltd., M€ annedorf, Switzerland).
Analysis of N-glycosylation sites in DPY19L3 and topological analysis of DPY19L3 by the introduction of N-glycosylation sites
To analyze the N-glycosylation sites in DPY19L3, 293T cells were transiently transfected with pCI-neo-DPY19L3 (wt, N118Q, N319Q, N439Q, N704Q, 2NQ, 2NQ + 141NV-in, or 2NQ + E206N)-Gluc using PEI Max. Twenty-four hours after transfection, cells were washed, harvested, and divided into two dishes. After addition of 24-h culture, cells were treated with or without 10 lgÁmL À1 tunicamycin, and the cultures continued for an additional 24 h. Cells were washed and lysed with lysis buffer [50 mM phosphate buffer, pH 7.5, 0.1% SDS, 0.75% Triton X-100, 50 mM 2-mercaptoethanol, and protease inhibitor cocktail (Nacalai Tesque, Kyoto, Japan)] at 4°C by sonication. The lysates were centrifuged at 16 000 g for 10 min and the supernatants were collected. The obtained samples were divided into two tubes and treated with or without 0.5 units PNGase F (Roche, Basel, Switzerland) at 37°C for 1 h. These samples were analyzed by western blot as described below.
Western blot
We performed western blot using a slightly modified version of previously described methods [43, [48] [49] [50] [51] . Cell lysates were mixed with loading buffer [58 mM Tris-HCl, pH 6.8, 5% (w/v) glycerol, 0.002% (w/v) bromophenol blue, 1% (w/v) SDS, and 5% (v/v) 2-mercaptoethanol]. Unboiled samples were electrophoresed on an SDS-polyacrylamide gel and transferred to polyvinylidene difluoride membranes. After being blocked, the membrane was immunoblotted with rabbit polyclonal anti-Gluc (#E8023S; New England Biolabs, Inc.). Subsequently, the membrane was incubated with secondary horseradish peroxidase (HRP)-conjugated donkey polyclonal anti-rabbit IgG (#NA934V; GE Healthcare, Little Chalfont, UK). After a wash step, the signals were detected using an enhanced chemiluminescence reagent (Immobilon Western Chemiluminescent HRP Substrate; Merck KGaA, Darmstadt, Germany).
Measurement of enzymatic activity of DPY19L3
To measure C-mannosyltransferase activity of DPY19L3, we performed gain-of-function experiments using S2 Drosophila melanogaster embryonic cells. S2 cells have no C-mannosyltransferase activity but possess dolichol-phosphate-mannose, which is used as a mannosyl donor substrate for C-mannosylation [12, 13, 35, 36] . S2 cells were transiently cotransfected with pIZ-DPY19L3 (wt, N118Q, N704Q, or isoform2)-myc and pMT-PURO-Rspo1-myc-his 6 using TransIT-Insect Transfection Regent (Mirus Bio LLC., Madison, WI, USA). After 6 h, the cells were cultured in serum-free medium with 700 lM CuSO 4 to induce Rspo1 expression; 66 h later, the culture media were collected and applied to heparin Sepharose beads (GE Healthcare). After 2 h of agitation, heparin Sepharose-bound proteins were eluted with 900 mM NaCl, and the eluate was further purified with Ni-NTA agarose (Qiagen, Hilden, Germany). Ni-NTA agarose-bound Rspo1 was eluted with 500 mM imidazole. For the LC-MS analysis, the resulting samples were electrophoresed on an SDS-polyacrylamide gel. Protein bands were visualized with Coomassie Brilliant Blue (CBB), and the CBB-stained bands that corresponded to Rspo1 were excised and destained. Furthermore, the cysteine residues in the bands were reduced with dithiothreitol and propionamidated with acrylamide. After a wash step, the bands were digested with TPCK-trypsin (Worthington Biochemical, Worthington, OH, USA) and an endoproteinase, Asp-N (Roche). Then, the digestion mixture was separated on a nanoflow LC (Easy nLC; Thermo Fisher Scientific, Waltham, MA, USA) using a spray column (NTCC analytical column, C18, φ75 lm 9 100 mm, 3 lm; Nikkyo Technos, Tokyo, Japan) with a linear gradient of 0-35% buffer B (100% acetonitrile and 0.1% formic acid) at a flow rate of 300 nLÁmin À1 over 10 min; this system was coupled online to a Q-Exactive mass spectrometer (Thermo Fisher Scientific) that was equipped with a nanospray ion source. MS/ MS data were acquired using targeted MS/MS according to an inclusion list. The selected ion chromatograms of targeted MS/MS spectra were generated in Qual Browser (Thermo Xcalibur 2.2 SP1.48, Thermo Fisher Scientific).
Immunofluorescence
To observe ER localization, we used a slightly modified version of previously described methods [13] . HT1080 cells were transfected with pAcGFP1-N1-DPY19L3 (wt, N118Q, N704Q, or isoform2) using Lipofectamine 3000 reagent (Thermo Fisher Scientific). Seventy-two hours after transfection, cells were selected with 400 lgÁmL À1 G418 (Roche) for about 2 weeks. Selected cells were grown on coverslips, washed with PBS, fixed with 4% paraformaldehyde for 10 min, and permeabilized with 0.1% Triton X-100 for 10 min. After a blocking step with 3% bovine serum albumin, the cells were incubated with mouse monoclonal anti-GFP (Santa Cruz Biotechnology, Inc., Dallas, TX, USA; sc-9996) and rabbit polyclonal anti-calnexin (Cell Signaling Technology, Danvers, MA, USA; 2433) for 1 h. Alexa Fluor488-conjugated anti-mouse IgG (Thermo Fisher Scientific) and Alexa Fluor568-conjugated anti-rabbit IgG (Thermo Fisher Scientific) were used as the secondary antibodies. After being washed two additional times, the cells were incubated with 2 lgÁmL À1 Hoechst 33258 (Polysciences, Inc.) for 10 min to stain the nuclei. The cells were washed with PBS and examined under a confocal laser scanning microscope (FLUO-VIEW FV10i; Olympus, Tokyo, Japan).
